Evidence map›Paper›PMID 10722626›Full record

ArticleInfection and immunity2000

Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.

Y Geng, K Berencsi, Z Gyulai, T Valyi-Nagy, E Gonczol, G Trinchieri

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. T cell-mediated host immune defenses in the lung.Annual review of immunology · 2013
    Review
  6. Article
  7. Article
  8. The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2010
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Y GengThe Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104, USA.
K Berencsi
Z Gyulai
T Valyi-Nagy
E Gonczol
G Trinchieri
The Wistar Institute · USVanderbilt University Medical Center · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
IMMUNOBIOLOGY OF INTERLUKIN-12R01AI034412 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J. · 1994 to 2003
$1.4M
DIFFERENTIATION AND FUNCTION OF MONOCYTESR01CA032898 · NCI · WISTAR INSTITUTE · PI SANTOLI, DANIELA · 1985 to 1994
–
NCI NIH HHS CA10815NCI NIH HHS CA32898NCI NIH HHS P30 CA010815NCI NIH HHS T32 CA009140NIAID NIH HHS AI34412NIAID NIH HHS R01 AI034412
6 · The paper itself

Abstract

BALB/c and strain 129 mice infected intranasally with Chlamydia pneumoniae displayed a moderate-to-severe inflammation in the lungs and produced interleukin-12 (IL-12), gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and IL-10, with peak levels on days 1 to 3 postinfection (p.i.), returning to basal levels by day 16 p.i. Anti-IL-12 treatment resulted in less-severe pathological changes but higher bacterial titers on days 3 and 7 p.i. By day 16 p.i., the inflammatory responses of control antibody-treated mice subsided. The bacterial titers of both anti-IL-12- and control antibody-treated mice decreased within 3 weeks to marginally detectable levels. Anti-IL-12 treatment significantly reduced lung IFN-gamma production and in vitro spleen cell IFN-gamma production in response to either C. pneumoniae or concanavalin A. In gamma-irradiated infected mice, cytokine production was delayed, and this delay correlated with high bacterial titers in the lungs. Following C. pneumoniae infection, 129 mice lacking the IFN-gamma receptor alpha chain gene (G129 mice) produced similar IL-12 levels and exhibited similarly severe pathological changes but had higher bacterial titers than 129 mice. However, by day 45 p.i., bacterial titers became undetectable in both wild-type 129 and G129 mice. Thus, during C. pneumoniae lung infection, IL-12, more than IFN-gamma, plays a role in pulmonary-cell infiltration. IFN-gamma and IL-12, acting mostly through its induction of IFN-gamma and Th1 responses, play an important role in controlling acute C. pneumoniae infection in the lungs, but eventually all mice control the infection to undetectable levels by IL-12- and IFN-gamma-independent mechanisms.

Indexed as

AnimalsAntibodies, MonoclonalChlamydia InfectionsChlamydophila pneumoniaeColony Count, MicrobialCytokinesImmunosuppression TherapyIn Situ HybridizationInterferon-gammaInterferon gamma ReceptorInterleukin-10Interleukin-12LungMaleMiceMice, Inbred BALB CAntibodies, MonoclonalCytokinesInterferon-gammaInterferon gamma ReceptorInterleukin-10Interleukin-12Receptors, InterferonTumor Necrosis Factor-alpha

Identifiers

PMID10722626
PMCPMC97410
OpenAlexW2130802589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.